India to get Remdesivir from Bangladesh next week
New Delhi: Bangladesh will be sending Remdesivir, an anti-viral medicine being used in Covid-19 treatment, along with other medical supplies to India next week, said country's Foreign Secretary Masud Bin Momen.
"India sought Remdesivir [from us]. We have taken measures to send it," Dhaka Tribune quoted Momen said on Thursday. The demand for the drug has recently increased in India, as the country witnessed a sudden rise in coronavirus cases.
The worsening Covid-19 situation has seen a surge in the demand for medical oxygen, drugs and beds for the Covid-19 patients and many states are reporting an acute shortage in essential medical supplies.
Last week, the Indian government waived import duty for the Remdesivir vials and the raw materials.
Bangladesh Foreign Ministry on Wednesday offered to dispatch emergency medicines and medical equipment supplies for the people of India who are fighting against the Covid-19 pandemic.
The supplies include about 10,000 vials of injectable anti-viral, oral anti-viral, 30,000 PPE kits, and several thousand zinc, calcium, vitamin C and other necessary tablets
About the risks of the Indian triple mutant Covid-19 variant entering Bangladesh, the foreign secretary said: "The situation in the country will be manageable if the infection rate goes down."
Bangladesh on April 25 closed its border with India for 14 days to control the spread of the deadly virus.
Read also: Covid-19: Govt to import 4.5 lakh vials of Remdesivir
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd